1127 Search Results for

IfPA Policy Brief Calls for Transparent Biosimilar Labeling

May 4, 2015

In the Institute for Patient Access’ new policy brief, “Informed Prescribing,” authors David Charles, MD, and Mary Ann Chapman, PhD, explain why biosimilar medications should come with transparent, accurate prescribing information.

Congress Urged to Prioritize Headache Research, Treatments

April 23, 2015

During today’s annual Headache on the Hill event, patients, physicians and advocates from the Alliance for Headache Disorders Advocacy will once again brief members of Congress on the impact of headache – and how better funding, more research and improved access to treatments could mitigate the conditions’ impact on patients.

AfPA Video Navigates Clinical Pathways’ Effect on Personalized Care

April 17, 2015

Will cost-focused clinical pathways derail personalized health care? A newly released video from the Alliance for Patient Access explores this question by considering how clinical pathways affect patients, their care regimen and their relationship with their health care providers.